Unknown

Dataset Information

0

Efficacy of Therapeutic Plasma Exchange in Patients with Severe Refractory Anti-NMDA Receptor Encephalitis.


ABSTRACT: The objective of the present study was to assess the efficacy of therapeutic plasma exchange (TPE) in patients with severe refractory anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis. Patients with severe anti-NMDA receptor encephalitis who showed no improvement after steroids and/or intravenous immunoglobulin treatment for at least 10 days were enrolled. All patients received immunotherapy and were divided into a TPE group and a non-TPE group according to treatment received. Each patient in the TPE group received at least 1 TPE course. NMDA receptor antibody titers in the cerebrospinal fluid (CSF) and plasma were evaluated within 1 week after the last TPE procedure. The clinical efficacy of treatment was evaluated after 1 month, 2 months, 3 months, 6 months, and 12 months. Forty patients were enrolled: 19 in the TPE group and 21 in the non-TPE group. Nineteen patients received TPE for a total of 118 procedures. NMDA receptor antibody titers in the CSF and/or plasma decreased or were negative after the last TPE procedure in 18 patients (94.7%). Compared with the non-TPE group, the TPE group exhibited greater clinical improvement after 1 month and 2 months following treatment (P?

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC6694354 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficacy of Therapeutic Plasma Exchange in Patients with Severe Refractory Anti-NMDA Receptor Encephalitis.

Zhang Yan Y   Liu Gang G   Jiang Mengdi M   Chen Weibi W   Su Yingying Y  

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20190701 3


The objective of the present study was to assess the efficacy of therapeutic plasma exchange (TPE) in patients with severe refractory anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis. Patients with severe anti-NMDA receptor encephalitis who showed no improvement after steroids and/or intravenous immunoglobulin treatment for at least 10 days were enrolled. All patients received immunotherapy and were divided into a TPE group and a non-TPE group according to treatment received. Each pat  ...[more]

Similar Datasets

| S-EPMC5945964 | biostudies-literature
| S-EPMC3795591 | biostudies-literature
| S-EPMC5297824 | biostudies-literature
| S-EPMC7983568 | biostudies-literature
| S-EPMC5899027 | biostudies-literature
| S-EPMC7327341 | biostudies-literature
| S-EPMC9826635 | biostudies-literature
| S-EPMC3039209 | biostudies-literature
| S-EPMC2868315 | biostudies-other
| S-EPMC10950913 | biostudies-literature